The global sales of respiratory gating are estimated to be worth USD 2,339.1 million in 2025 and are anticipated to reach a value of USD 4,788.7 million by 2035. Sales are projected to rise at a CAGR of 7.5% over the forecast period between 2025 and 2035. The revenue generated by respiratory gating in 2024 was USD 2,162.5 million.
The Respiratory Gating Market represents an important part of the medical imaging and therapeutic landscape, which is intended to enhance the accuracy of diagnosis and treatment procedures by considering natural motions of the heart and lungs. Gating systems are being used to coordinate imaging with therapeutic interventions at either cardiac or respiratory cycles, which yield clear visualization and precise targeting.
Increased incidents of cancer and cardiovascular disorders require more advanced solutions in diagnosis and imaging for treatment. It increases demand on the market. In general, this is about better diagnostic and therapeutic precision facilitated by these systems, without which contemporary medicine could not get along. In addition, there is increased adoption of minimally invasive procedures and image-guided therapies that boost demand for the usage of technologies pertaining to gating.
Respiratory gating Industry Assessment
| Attributes | Key Insights |
|---|---|
| Estimated Size, 2025 | USD 2,339.1 million |
| Projected Size, 2035 | USD 4,788.7 million |
| Value-based CAGR (2025 to 2035) | 7.5% |
The respiratory gating industry ensures better accuracy in diagnosis imaging and therapeutic procedures by dealing with the natural motion of the heart and lungs. Various respiratory gating systems synchronize the imaging and treatment with cardiac or respiratory cycles that allow for the precise targeting and clear visualization of tumors, especially in applications like radiotherapy, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine. These systems are irreplaceable in the management of complex conditions, including cancers, cardiovascular diseases, and respiratory disorders.
The other major driving force of the market is technological advancements. Innovations in software-based gating systems, integration of AI, and hybrid imaging techniques raise the efficiency and usability of the technologies substantially. These fall in line with increasing focus on personalized medicine and precision oncology, where the use of a gating system is considered important for tailored patient-specific treatment outcomes.
Besides, new healthcare infrastructure in the developing part of the world offers broad prospects for the growth of the market. There has been a considerable increase in governments and private players investing in better diagnostic facilities to aid the diagnostics market. This trend has, in turn, influenced greater adoption of gating technologies. However, high system costs and limited accessibility of resources in low-resource settings threaten to hamper its market diffusion.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Increasing Need for Minimally Invasive Procedures Driving Market Growth
The shift towards minimal invasiveness in health has redefined diagnosis and the treatment of cardiac and respiratory conditions. These techniques are preferred by patients and caregivers due to the reduced recovery times post-operatively, lower chances of developing complications, and comparatively reduced risks compared to those of open-heart surgeries.
Respiratory gating technologies reduce the motion artifacts seriously impeding imaging accuracy, especially when one is concerned with dynamic organs like the heart and lungs. Motions due to patient breathing or heartbeat disturb the process of imaging and make the surgeon's attempt to target certain areas not quite effective in MIPs. The interventions performed by minimally invasive techniques include catheter-based interventions, endoscopic procedures, and targeted radiotherapy for cardiac and respiratory diseases.
Gating systems that are frequently used in procedures such as lung cancer radiotherapy. Varian Medical Systems is one of the pioneer in gating technology used for radiotherapy, enabling hospital settings to deliver more effective and safer treatments for lung cancer patients. In conclusion, the increasing need for minimally invasive procedures across other cardiology and pulmonology remains a key driver for the respiratory gating sector.
Climbing Cancer Cases and Demand for Precision Radiotherapy Driving Growth in Respiratory Gating
The incidence of lung cancer is on the rise globally and the demand for advanced imaging is also on rise along with radiotherapy.In few cases, especially those that are closer to vital organs such as lungs and heart, targeted radiation should be extremely accurate in order to avoid healthy tissue. Respiratory gating systems found their appropriate application in this case, which consists of synchronizing the delivery of radiation with a patient's breathing cycle or heartbeat for accuracy and patient safety.
For example, lung cancer is a very prominent condition where respiratory gating is useful. Since lung tumors move with the breathing of the patient, standard radiotherapy risks exposing healthy lung tissue surrounding the tumor to radiation. The treatment is allowed to occur only when the tumor is in its designated position, thereby reducing the radiation exposure to healthy tissues.
Studies have proven that respiratory gating can reduce radiation exposure to healthy lung tissue by 20% to 30%, which significantly decreases the risk of side effects. Major cancer treatment centers, such as Memorial Sloan Kettering Cancer Center, have incorporated gating technologies into their protocols to increase precision in lung cancer radiotherapy.
Overall, the growth of treatments that involve radiotherapy and proton therapy is seen as an important driver in respiratory gating. Improved accuracy in treatment does help lower complications, increase the safety margin for patients, and thus furthers the trend in the industry toward personalized, non-invasive cancer care.
Integration of Gating Systems in High-Precision Treatments Strengthening Market Growth
Precision medicine aims to enhance therapeutic results by reducing damage to healthy tissues and optimizing intervention in diseased areas. This evolution is giving a strong opportunity for respiratory gating technologies, which enable imaging and treatment systems to track patient movements and improve accuracy in treatments targeting specific anatomical sites.
Respiratory gating systems play a particularly important role in precision medicine by allowing medical interventions to be scheduled in tandem with the patient's body's natural cycles, such as breathing or heartbeats. This is especially important when trying to treat cancerous areas located near moving organs, like the lungs or heart. For instance, in lung cancer treatments, gating systems may be used so that the tumors can be targeted accurately with minimal effects on the adjacent healthy tissues. Lung cancer therapy also requires precise radiation doses, eliminates harmful exposure to critical areas because gating systems ensure the matching of radiation delivery to a patient is breathing cycle, and thus enhances safety and efficiency.
Gating systems help stabilize the imaging process, ensuring that only accurate and timely information is captured for diagnosis and treatment planning. Gating systems help stabilize the imaging process, ensuring that only accurate and timely information is captured for diagnosis and treatment planning. By supporting targeted and patient-specific interventions, gating systems are set to become a cornerstone of the expanding the respiratory gating revenue.
High Cost of Gating Systems and Procedures May Restrict Market Growth
The cost associated with respiratory gating systems is a significant barrier to adoption, especially for those healthcare facilities that operate on limited budgets. Gating systems require considerable initial investment since the technology relies on sophisticated equipment, which integrates seamlessly with the imaging and radiotherapy platforms. For example, the modern gating systems must be able to synchronize with advanced imaging modalities such as MRI and CT, which requires high-end components and precision engineering, all of which increase the overall cost.
Over and above the initial cost, there are also costs related to the maintenance of the systems. Maintenance involves highly technical support, hardware upgrades, software upgrades, among other things, and expensive replacement parts at times. This results in considerable lifecycle costs for gating systems, which may not be feasible for many small or mid-sized hospitals or clinics, especially in underfunded healthcare systems.
The high cost limits the adoption of gating systems primarily to well-funded institutions or private practices in affluent areas. This cost barrier restricts the market size and may prevent the technology from reaching a broader patient base who could benefit from enhanced imaging precision.
The global respiratory gating industry recorded a CAGR of 5.3% during the historical period between 2020 and 2024. The growth of respiratory gating industry was positive as it reached a value of USD 2,162.5 million in 2024 from USD 1,703.9 million in 2020.
The technique of respiratory gating has seen unprecedented growth in the last ten years owing to advances in medical imaging and increased demand for correct diagnosis and focused therapy. Respiratory gating initially found application primarily in radiation therapy, especially in the field of cancer treatments, because they avoid the artifacts caused by heart and lung movements. However, as advancements in imaging technologies, including CT, MRI, and PET, developed with the need for a gating system, the technology had to be used across cardiac imaging, diagnosis of respiratory diseases, personalized medicine, among others.
The market is presently recording a quick growth rate due to the integrations of advanced technologies such as AI and software-based gating systems. Precise medicine approaches for oncology and cardiology are driving the growth of respiratory gating systems.
The market is expected to continue its growth curve with considerable growth over the next decade. Advancements in technology, including AI-powered gating systems and hybrid imaging techniques, would further enhance the accuracy and speed of diagnostics and treatments. Although the aforementioned barriers are there, the respiratory gating future outlook remains encouraging, with continuous advancements in technology and growing global healthcare needs driving its expansion.
Tier 1 companies dominate the market, gaining the highest share from their superior technological offerings and massive investments in R&D, capturing significant market share of 69.1% in global market. Some of the noted players in this tier include Siemens Healthineers, GE HealthCare, Philips Healthcare (Koninklijke Philips N.V.A) and Canon Medical Systems Corporation
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market and holds around 22.7% market share. One of the most important companies in this category is Fujifilm Holdings Corporation, Elekta, Accuray Incorporated, Brainlab AG, Schiller AG, Vision RT Ltd. among others
Finally, Tier 3 companies, such as C-RAD, MIM Software Inc., Ivy Biomedical Systems, Inc, SDX (DYN’R Medical Systems) Anzai Medical, Co., Ltd among others are essential for the market, and holds around 14.1% market share.
The section below covers the industry analysis for the Respiratory Gating Market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with a CAGR of 4.3% through 2035. In Asia Pacific, China is projected to witness a CAGR of 13.0% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 4.3% |
| Germany | 6.1% |
| France | 7.6% |
| UK | 8.8% |
| China | 13.0% |
| India | 8.5% |
United States market is anticipated to grow at a CAGR of 4.3% throughout the forecast period. Integration of respiratory gating systems with real-time imaging techniques is now an emerging key driver in the USA, which considerably enhances the accuracy of diagnosis and treatment procedures.
Most of the conventional imaging technologies often present motion artifacts due to respiratory and cardiac rhythms, which may lead to potential inaccuracies. With the introduction of real-time imaging techniques such as 4D CT and dynamic MRI, the ability to smoothly synchronize gating systems with patient movements improved substantially. Hence, sharper images for more precise diagnosis will perfectly fit into the USA philosophy of advanced, high-quality care.
For instance, leading companies like Philips have launched 4D imaging systems synchronized for the USA market, reducing motion-related errors and improving the patient experience. This kind of innovation is considered very valuable in handling the complex cases of irregular heartbeat and variable breathing patterns that improve the management of highly prevalent cardiovascular and respiratory diseases within the country.
Germany’s market for respiratory gating is expected to exhibit a CAGR of 6.1% between 2025 and 2035. The Germany holds highest market share in European market.
The development and adoption of portable and point-of-care respiratory gating devices are acting as significant drivers in the German market, with much need for flexible and efficient health care solutions. Portable respiratory gating systems ensure that hospitals and clinics save space and resources by not necessarily requiring special areas for imaging. This is especially useful in Germany, where health care providers work to maximize efficiency and facility management.
Further, the systems are installed in the rural and under-reserved sections of Germany, where facilities for higher-order imaging cannot be availed. This provides state-of-the-art gating technology in areas that otherwise have limited access to top-notch diagnostic and treatment services, thus bridging gaps in health care. This also aligns with the commitment of Germany to full and accessible health care across both urban and rural areas, hence forcing the adoption of portable respiratory gating devices as an essential innovation within the market.
India is expected to hold dominating position in South Asian market of respiratory gating and is anticipated to grow at a CAGR of 8.5% throughout the forecast period.
Pediatric imaging is becoming one of the major drivers that can mark the adoption rate of respiratory gating systems in India, addressing many unique challenges faced while scanning young patients. Children typically cannot stay still during any kind of imaging, often resulting in motion artifacts, or yielding distorted images, many times necessitating repeated studies. This not only deprives one of diagnostic certainty but also enhances radiation exposure time and makes the imaging process no less stressful for both patient and caregiver.
Respiratory gating systems are increasingly becoming more useful and popular in the pediatric radiology sector in India: Imaging would be synchronized with natural breathing in a child as it ensures high-quality capture even if the child unpredictably moves or breaths during the test.
This is particularly important for MRI and CT scans, where any slight movement can lead to deterioration in image quality and may lead to radiologists missing out on anomalies. These systems will contribute to enhancing the efficiency and effectiveness of India's healthcare, where increased access to health facilities calls for more advanced diagnostic solutions.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section contains information about the leading segments in the industry. Based on product, systems with in-built gating are expected to account for 22.3% of the global market share in 2025.
| Product type | Value Share (2025) |
|---|---|
| Systems with In-built Gating | 54.1% |
Systems with in-built gating lead the market for respiratory gating due to seamless integration and superior efficiency of the diagnosis and therapeutic procedure. These systems integrate imaging and gating into one system, and no additional hardware or software add-ons are required. This simplifies the work and reduces setup time, enhancing accuracy; hence, these are the first choices for many healthcare providers around the world.
Systems with in-built gating are designed with advanced algorithms, artificial intelligence, AI, and machine learning. These improve motion detection and synchronization accuracy. With that capability to deliver quality, consistent output even in adverse conditions, the demand for in-built gating systems in hospitals, outpatient facilities, and specialized diagnostic areas has become imperative.
| By Gating Type | Value Share (2025) |
|---|---|
| Respiratory Gating | 38.9% |
Respiratory gating currently leads the market for respiratory gating because it forms the pivot upon which the development of new imaging accuracy and treatment precision in areas where the amplitude of respiratory motion is significant can be realized.
Respiratory gating technology synchronizes imaging and therapeutic procedures with the respiratory cycle of the patient-a capability that ensures motion induced by respiration does not degrade the quality of the results.
This capability is particularly important when imaging the thoracic and abdominal regions, where respiratory motion can blur anatomical detail and may lead to mistakes in diagnosis or suboptimal therapeutic targeting. In general, this important role of respiratory gating in both diagnostic and therapeutic applications keeps respiratory gating in the leading position in the Respiratory Gating Market.
The Respiratory Gating Market is highly competitive with many key players actively working hard to both maintain and even enhance their market positions. Major players in this industry are concentrating on innovation, investing highly in more advanced technologies and applications to cater for different needs healthcare providers and patients have. Such strategic approaches include forming strategic partnerships, mergers, and acquisitions to expand the product portfolios and geographic reach of such companies.
Recent Industry Developments in Respiratory Gating Market
In terms of product, the industry is divided into Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy), Standalone Gating Systems (CT, MRI, PET, SPECT and Radiotherapy), and Software (Cardiac Gating Software and Respiratory Gating Software)
In terms of modality, the industry is divided into CT, MRI, PET, SPECT and Radiotherapy
In terms of gating type, the industry is divided into Cardiac Gating, Respiratory Gating and Multimodality Gating
In terms of technology, the industry is divided into ECG-triggering, Optical Surface Monitoring, Pressure Sensor Based, and Electromagnetic among others
In terms of end user, the industry is divided into Hospitals, Specialty Clinics, Imaging and Diagnostic Centers, Cancer Treatment and Radiotherapy Centers and Academic & Research Institutions
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
The global respiratory gating industry is projected to witness CAGR of 7.5% between 2025 and 2035.
The global respiratory gating industry stood at USD 2,162.5 million in 2024.
The global respiratory gating industry is anticipated to reach USD 4,788.7 million by 2035 end.
France is expected to show a CAGR of 7.6% in the assessment period.
The key players operating in the global respiratory gating industry include Siemens Healthineers, Philips Healthcare, Canon Medical Systems, GE HealthCare, Fujifilm, Brainlab AG, Vision RT Ltd., Anzai Medical, Co., Ltd, Schiller AG, C-RAD, Elekta, Accuray Incorporated, MIM Software Inc., Raditec Medical AG, Ivy Biomedical Systems, Inc, SDX (DYN’R Medical Systems) and Cardiac Imaging, Inc.
Explore Diagnostic Devices Insights
View Reports
Respiratory Gating Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
